This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Is It Wise to Retain Henry Schein (HSIC) in Your Portfolio Now?
by Zacks Equity Research
Robust acquisitions and a widespread distribution network bode well for Henry Schein's (HSIC) operations.
HSICPositive Net Change HAENegative Net Change MEDPNegative Net Change HIMSPositive Net Change
medical medical-devices
Implied Volatility Surging for AdaptHealth (AHCO) Stock Options
by Zacks Equity Research
Investors need to pay close attention to AdaptHealth (AHCO) stock based on the movements in the options market lately.
AHCOPositive Net Change
medical medical-devices
Implied Volatility Surging for Labcorp (LH) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Labcorp (LH) stock based on the movements in the options market lately.
LHPositive Net Change
medical medical-devices
Here's Why You Should Add DaVita (DVA) to Your Portfolio
by Zacks Equity Research
DaVita's (DVA) strength in its kidney care raises optimism about the stock.
UHSPositive Net Change ISRGNegative Net Change DVANegative Net Change DXCMNegative Net Change
medical medical-devices
Masimo (MASI) Gets Non-Binding Offer for Consumer Business
by Zacks Equity Research
Masimo (MASI) gets an acquisition offer for its consumer business from an undisclosed entity. The deal is likely to close later in 2024.
UHSPositive Net Change DVANegative Net Change MASIPositive Net Change DXCMNegative Net Change
medical medical-devices
GE HealthCare's (GEHC) New Solution to Aid Prostate Treatment
by Zacks Equity Research
GE HealthCare's (GEHC) MIM Software introduced the MIM Symphony HDR Prostate to provide direct tumor visualization using MRI images during live ultrasound procedures for HDR prostate treatments.
UHSPositive Net Change SYKNegative Net Change DVANegative Net Change GEHCPositive Net Change
medical medical-devices
Here's Why You Should Retain Nevro (NVRO) Stock for Now
by Zacks Equity Research
Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.
UHSPositive Net Change SYKNegative Net Change DVANegative Net Change NVROPositive Net Change
medical medical-devices
Microbot Medical (MBOT) Progresses in Its Human Clinical Trial
by Zacks Equity Research
Microbot Medical's (MBOT) latest patient enrollment in its pivotal human clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY system.
SYKNegative Net Change DVANegative Net Change MBOTNegative Net Change ELVPositive Net Change
medical medical-devices
IceCure's (ICCM) ProSense Breast Cancer Study Meets Endpoint
by Zacks Equity Research
IceCure's (ICCM) ProSense cryoablation system demonstrated a 100% complete ablation rate for breast cancer per a study published in "Cancers."
UHSPositive Net Change DVANegative Net Change DXCMNegative Net Change ICCMNegative Net Change
medical medical-devices
Here's How Abbott (ABT) is Placed Ahead of Q2 Earnings Release
by Zacks Equity Research
Abbott Laboratories' (ABT) second-quarter 2024 results are likely to reflect broad-based strength across several businesses and solid progress in the pipeline.
ABTNegative Net Change HCAPositive Net Change HIMSPositive Net Change ENOVPositive Net Change
earnings medical medical-devices
Should You Buy Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ATATNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Baxter (BAX) Shares Rise 2.4% in July: Will It Go Higher?
by Zacks Equity Research
Shares of Baxter (BAX) are showing signs of stability after falling in the first half of 2024. Let's see what is driving investors' sentiment for the company.
BAXNegative Net Change DXCMNegative Net Change CGPositive Net Change GKOSNegative Net Change
medical medical-devices
Reasons to Add Intuitive Surgical (ISRG) to Your Portfolio Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.
UHSPositive Net Change ISRGNegative Net Change DVANegative Net Change DXCMNegative Net Change
medical medical-devices
Top Medical Stocks to Buy for Growth & Performance
by Shaun Pruitt
The medical sector is crawling with opportunity as indicated in its representation on the Zacks Rank #1 (Strong Buy) list.
HAENegative Net Change HALOPositive Net Change NBIXPositive Net Change
cancer earnings hospitals investing medical medical-devices oncology-screening pharmaceuticals
3 Reasons Why You Should Hold Avantor (AVTR) Stock for Now
by Zacks Equity Research
Avantor's (AVTR) strong product portfolio raises optimism about the stock.
ECLNegative Net Change SYKNegative Net Change DVANegative Net Change AVTRPositive Net Change
medical medical-devices
Orthofix Medical's (OFIX) Fitbone System Gets FDA Clearance
by Zacks Equity Research
Orthofix Medical (OFIX) announces the FDA clearance and first U.S. implant of the Fitbone Transport and Lengthening System, used to treat large bone defects in the femur and tibia.
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change OFIXNegative Net Change
medical medical-devices
Masimo (MASI) Preliminary Q2 Results Aided by Healthcare Unit
by Zacks Equity Research
Masimo's (MASI) second-quarter 2024 results are likely to reflect the strength in the Healthcare business.
ECLNegative Net Change SYKNegative Net Change DVANegative Net Change MASIPositive Net Change
medical medical-devices
Inspire Medical (INSP) Dips on FDA Recall of IPG Model 3028
by Zacks Equity Research
The recall of Inspire Medical 's (INSP) Inspire IV Implantable Pulse Generators might dampen the company's future sales.
ECLNegative Net Change UHSPositive Net Change DVANegative Net Change INSPNegative Net Change
medical medical-devices
Axcelis Technologies (ACLS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ACLSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Myriad Genetics (MYGN) Advances in MRD Space With New Patent
by Zacks Equity Research
Myriad Genetics (MYGN) achieves a second foundational patent bolstering the MRD assay development.
HAENegative Net Change MYGNNegative Net Change MEDPNegative Net Change HIMSPositive Net Change
medical medical-devices
Olink's (OLK) Acquisition by Thermo Fisher Gets UK CMA Nod
by Zacks Equity Research
Olink's (OLK) buyout by Thermo Fisher gets CMA's approval, signaling regulatory confidence in the merger's compliance with competition laws.
UHSPositive Net Change DVANegative Net Change TMOPositive Net Change
medical medical-devices
Stryker (SYK) Gains 11.6% YTD: What's Driving the Stock?
by Zacks Equity Research
Styker's (SYK) flagship Mako Total Knee Platform and a diversified product portfolio raise optimism about the stock.
ECLNegative Net Change UHSPositive Net Change SYKNegative Net Change DVANegative Net Change
medical medical-devices
Charles River (CRL) Teams Up to Aid Stargardt's Disease Therapy
by Zacks Equity Research
Charles River (CRL) signs an agreement with AAVantgarde to produce GMP plasmid DNA for Stargardt's disease program.
DXCMNegative Net Change CRLNegative Net Change MEDPNegative Net Change HIMSPositive Net Change
medical medical-devices
Here's Why Holding Align Technology (ALGN) Stock Could Pay Off
by Zacks Equity Research
Align Technology's (ALGN) Invisalign portfolio expansion efforts spark optimism.
ALGNNegative Net Change PENNegative Net Change MEDPNegative Net Change HIMSPositive Net Change
medical medical-devices
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Eaton, Palo Alto, Keurig Dr Pepper and Yum! Brands
by Zacks Equity Research
Thermo Fisher Scientific, Eaton, Palo Alto, Keurig Dr Pepper and Yum! Brands are included in this Analyst Blog.
ETNNegative Net Change YUMPositive Net Change TMOPositive Net Change PANWNegative Net Change KDPPositive Net Change
medical-devices